18F‐fluoro‐2‐deoxy‐2‐d‐glucose PET‐CT (FDG PET‐CT) in staging of high‐risk renal and urothelial bladder cancers (COPPER‐T) trial protocol

18F‐fluoro‐2‐deoxy‐2‐d‐glucose PET‐CT (FDG PET‐CT) in staging of high‐risk renal and urothelial bladder cancers (COPPER‐T) trial protocol

Abstract Background and Study Design Role of 18F‐fluoro‐2‐deoxy‐2‐d‐glucose positron emission tomography‐computed tomography (FDG PET‐CT) in evaluation of renal cell cancers (RCC) and urinary bladder cancers is not standardized, and the COPPER‐T trial, which is a single centre prospective randomized...

Full description

Bibliographic Details
Main Authors: Rahul Jena, Priyank Bhargava, Shashank Tripathi, Sameer Taywade, Taruna Yadav, Arjun Singh Sandhu, Mahendra Singh, Shiv Charan Navriya, Deepak Prakash Bhirud, Amit Aggarwal, Gautam Ram Choudhary
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:BJUI Compass
Subjects:
bladder cancer
conventional imaging
FDG PET‐CT
high risk urothelial cancer
randomized trial
renal cell carcinoma
Online Access:https://doi.org/10.1002/bco2.246

Similar Items

Similar Items